close
Fox News Flash top headlines are here. Check out what’s clicking on Foxnews.com.
A Japanese health ministry panel on Monday recommended approval of the Alzheimer’s disease treatment Leqembi, following standard approval for the drug granted by U.S. regulators last month.
REVANCE’S BOTOX RIVAL GETS FDA APPROVAL FOR PAINFUL NECK MUSCLE CONDITION
The expert panel’s decision sets the stage for official approval of the drug, co-developed by Japan’s Eisai and U.S.-based Biogen.
Dr. Seth Gale points out evidence of Alzheimer’s disease on PET scans at the Center for Alzheimer Research and Treatment (CART) at Brigham and Women’s Hospital in Boston, Massachusetts, on March 30, 2023. (REUTERS/Brian Snyder/File Photo)
An Eisai executive said this month the company expects to begin marketing Leqembi in Japan within about 60 days of receiving insurance reimbursement approval from the country’s national health system.
CLICK HERE TO GET THE FOX NEWS APP
close Video Fox News Flash top headlines for January 30 Fox News Flash top headlines…
close Video DC plane crash air traffic control audio reveals moment controllers saw disaster Air…
Sen. Adam Schiff, D-Calif., clashed with FBI director nominee Kash Patel during his confirmation hearing…
The Federal Communications Commission (FCC) launched an investigation into media outlets PBS and National Public…
EXCLUSIVE: The top Republican on the House Transportation Committee’s subcommittee on aviation is calling for…
Conservatives on social media praised Kash Patel, President Donald Trump's nominee for FBI director, after…